Clinical Trials Browser

Interventional × Neoplasms × sapanisertib × Clear all

NCT03017833 2023-10-04

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms